NCT03240211: Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL |
|
|
| Recruiting | 1 | 37 | US | Pembrolizumab, Keytruda, Pralatrexate, Folotyn, Decitabine, Dacogen | University of Virginia, Merck Sharp & Dohme LLC, Otsuka Pharmaceutical Development & Commercialization, Inc. | PTCL, CTCL | 06/25 | 12/25 | | |